Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Adamis Pharmaceuticals Co...

    NASDAQ: ADMP · Real-Time Price · USD
    0.78
    0.01 (1.50%)
    At close: Sep 07, 2023, 9:59 PM

    Adamis Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 4.76M 2.21M
    Cost of Revenue
    		 6.19M 6.87M
    Gross Profit
    		 -1.43M -4.66M
    Operating Income
    		 -25.06M -32.07M
    Interest Income
    		 44.13K n/a
    Pretax Income
    		 -26.2M -34.6M
    Net Income
    		 -26.2M -34.6M
    Selling & General & Admin
    		 13.25M 16.14M
    Research & Development
    		 10.38M 11.26M
    Other Expenses
    		 n/a 7.22K
    Operating Expenses
    		 23.63M 27.41M
    Interest Expense
    		 44.13K 6.65K
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 29.82M 34.28M
    Income Tax Expense
    		 2K 796.00
    Shares Outstanding (Basic)
    		 2.14M 2.06M
    Shares Outstanding (Diluted)
    		 2.14M 2.06M
    EPS (Basic)
    		 -12.24 -16.8
    EPS (Diluted)
    		 -12.24 -16.8
    EBITDA
    		 -24.27M -30.63M
    EBIT
    		 -1.16B -34.59M
    Depreciation & Amortization
    		 791.34K 1.44M

    Add to Watchlist